Aventis Pasteur Limited

Organization

Toronto, CA

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Patent number 7,335,370
- Issue date Feb 26, 2008
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transferrin receptor genes of moraxella
- Patent number 7,241,449
- Issue date Jul 10, 2007
- Aventis Pasteur Limited
- Lisa E. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Co-expression of recombination proteins
- Patent number 7,015,033
- Issue date Mar 21, 2006
- Aventis Pasteur Limited
- Sheena M. Loosmore
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Non-infectious, non-replicating, immunogenic human immunodeficiency...
- Patent number 7,008,784
- Issue date Mar 7, 2006
- Aventis Pasteur Limited
- Joel Haynes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multi-component vaccine comprising at least two antigens from haemo...
- Patent number 6,974,581
- Issue date Dec 13, 2005
- Aventis Pasteur Limited
- Sheena M. Loosmore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Patent number 6,872,814
- Issue date Mar 29, 2005
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrophage-infecting parasites expressing a granulocyte macrophage...
- Patent number 6,855,537
- Issue date Feb 15, 2005
- Aventis Pasteur Limited
- Barbara Papadopoulu
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Grant
Protective recombinant Haemophilus influenzae high molecular weight...
- Patent number 6,849,447
- Issue date Feb 1, 2005
- Aventis Pasteur Limited
- Sheena M. Loosmore
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunogenic compositions for protection against chlamydial infection
- Patent number 6,811,783
- Issue date Nov 2, 2004
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Patent number 6,808,713
- Issue date Oct 26, 2004
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adjuvant compositions containing more than one adjuvant
- Patent number 6,764,682
- Issue date Jul 20, 2004
- Aventis Pasteur Limited
- Ali Kandil
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecules encoding POMP91A protein of Chlamydia
- Patent number 6,693,087
- Issue date Feb 17, 2004
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding inclusion membrane protein C of Chl...
- Patent number 6,686,339
- Issue date Feb 3, 2004
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid respiratory syncytial virus vaccines
- Patent number 6,677,127
- Issue date Jan 13, 2004
- Aventis Pasteur Limited
- Xiaomao Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Two-step immunization procedure against Chlamydia infection
- Patent number 6,676,949
- Issue date Jan 13, 2004
- University of Manitoba
- Robert C. Brunham
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Patent number 6,660,275
- Issue date Dec 9, 2003
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi oligosaccharide glycoconjugate bacterial meningitis vaccines
- Patent number 6,656,472
- Issue date Dec 2, 2003
- Aventis Pasteur Limited
- Pele Chong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Patent number 6,649,370
- Issue date Nov 18, 2003
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Patent number 6,642,025
- Issue date Nov 4, 2003
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chlamydial vaccines and immunogenic compositions containing an oute...
- Patent number 6,635,746
- Issue date Oct 21, 2003
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA immunization against chlamydia infection
- Patent number 6,632,663
- Issue date Oct 14, 2003
- Aventis Pasteur Limited
- Robert C. Brunham
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Biodegradable targetable microparticle delivery system
- Patent number 6,623,764
- Issue date Sep 23, 2003
- Aventis Pasteur Limited
- Kenneth K. Sokoll
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Grant
Constitutive expression of non-infectious HIV-like particles
- Patent number 6,572,863
- Issue date Jun 3, 2003
- Aventis Pasteur Limited
- Benjamin Rovinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Attenuated strains of mycobacteria
- Patent number 6,548,070
- Issue date Apr 15, 2003
- Aventis Pasteur Limited
- Bruno Flesselles
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Non-infectious, immunogenic, human immunodeficiency virus-like part...
- Patent number 6,544,527
- Issue date Apr 8, 2003
- Aventis Pasteur Limited
- Benjamin Rovinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anigenically-marked non-infectious retrovirus-like particles
- Patent number 6,544,752
- Issue date Apr 8, 2003
- Aventis Pasteur Limited
- Benjamin Rovinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Continuous adherent melanocyte cell line
- Patent number 6,541,250
- Issue date Apr 1, 2003
- Aventis Pasteur Limited
- Jeannine Alexander
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecules encoding inclusion membrane protein C of Chl...
- Patent number 6,521,745
- Issue date Feb 18, 2003
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigentically-marked non-infectious retrovirus-like particles
- Patent number 6,518,030
- Issue date Feb 11, 2003
- Aventis Pasteur Limited
- Benjamin Rovinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Attenuated strains of mycobacteria
- Patent number 6,503,514
- Issue date Jan 7, 2003
- Aventis Pasteur Limited
- Bruno Flesselles
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
TUMOR ANTIGENS BFA4 AND BCY1 FOR PREVENTION AND / OR TREATMENT OF C...
- Publication number 20110117640
- Publication date May 19, 2011
- Aventis Pasteur, Ltd.
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHLAMYDIA ANTIGENS AND PROTEIN VACCINE
- Publication number 20090155350
- Publication date Jun 18, 2009
- Aventis Pasteur Limited
- ANDREW D. MURDIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHLAMYDIA POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS AND USES THE...
- Publication number 20090142376
- Publication date Jun 4, 2009
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chlamydia OMP antigen
- Publication number 20080112965
- Publication date May 15, 2008
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chlamydia flagellar protein antigen
- Publication number 20080095793
- Publication date Apr 24, 2008
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid and amino acid sequences relating to Streptococcus pne...
- Publication number 20070031852
- Publication date Feb 8, 2007
- Aventis Pasteur Ltd
- Lynn Doucette-Stamm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid and amino acid sequences relating to streptococcus pne...
- Publication number 20070009904
- Publication date Jan 11, 2007
- Aventis Pasteur Ltd
- Lynn Doucette-Stamm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid and amino acid sequences relating to Streptococcus pne...
- Publication number 20070009900
- Publication date Jan 11, 2007
- Aventis Pasteur Ltd
- Lynn Doucette-Stamm
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nucleic acid and amino acid sequences relating to Streptococcus pne...
- Publication number 20070009901
- Publication date Jan 11, 2007
- Aventis Pasteur Ltd
- Lynn Doucette-Stamm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid and amino acid sequences relating to streptococcus pne...
- Publication number 20070009905
- Publication date Jan 11, 2007
- Aventis Pasteur Ltd
- Lynn Doucette-Stamm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid and amino acid sequences relating to streptococcus pne...
- Publication number 20070009906
- Publication date Jan 11, 2007
- Aventis Pasteur Ltd
- Lynn Doucette-Stamm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid and amino acid sequences relating to Streptococcus pne...
- Publication number 20070009903
- Publication date Jan 11, 2007
- Aventis Pasteur Ltd
- Lynn Doucette-Stamm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid and amino acid sequences relating to Streptococcus pne...
- Publication number 20070009902
- Publication date Jan 11, 2007
- Aventis Pasteur Ltd
- Lynn Doucette-Stamm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intranasal delivery of pneumococcal polysaccharide vaccines
- Publication number 20060140981
- Publication date Jun 29, 2006
- Aventis Pasteur SA
- Ingileif Jonsdottir
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multi-antigen vectors of melanoma
- Publication number 20060127360
- Publication date Jun 15, 2006
- Aventis Pasteur, Ltd.
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Publication number 20050220805
- Publication date Oct 6, 2005
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chlamydia antigens and vaccine uses of the protein
- Publication number 20050202048
- Publication date Sep 15, 2005
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Publication number 20050186266
- Publication date Aug 25, 2005
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tumor antigen BFA5 for prevention and / or treatment of cancer
- Publication number 20050112099
- Publication date May 26, 2005
- Aventis Pasteur, Ltd.
- Neil Berinstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Publication number 20050069942
- Publication date Mar 31, 2005
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Assaying the teichoic acids of gram+ bacteria
- Publication number 20050009121
- Publication date Jan 13, 2005
- Aventis Pasteur SA
- Philippe Talaga
- G01 - MEASURING TESTING
Information Patent Application
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Publication number 20050002944
- Publication date Jan 6, 2005
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adjuvant for vaccine composition
- Publication number 20050002952
- Publication date Jan 6, 2005
- Aventis Pasteur SA
- Jean Haensler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Publication number 20050002960
- Publication date Jan 6, 2005
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Enhancement of the immune response using CD36-binding domain
- Publication number 20040241652
- Publication date Dec 2, 2004
- Aventis Pasteur Limited
- William I. Cox
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Vaccine composition comprising iron phosphate as vaccine adjuvant
- Publication number 20040228880
- Publication date Nov 18, 2004
- Aventis Pasteur SA
- Elisabeth Sauzeat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of c...
- Publication number 20040197912
- Publication date Oct 7, 2004
- Aventis Pasteur, Ltd.
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Conjugates obtained by reductive amination of the pneumococcus sero...
- Publication number 20040170638
- Publication date Sep 2, 2004
- Aventis Pasteur, S.A.
- Noelle Mistretta
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Application
Chlamydia antigens and corresponding DNA fragments and uses thereof
- Publication number 20040086525
- Publication date May 6, 2004
- Aventis Pasteur Limited
- Andrew D. Murdin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Targeted immunogens
- Publication number 20040002455
- Publication date Jan 1, 2004
- Aventis Pasteur, Ltd.
- Robert Adam Uger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Aventis Pasteur Limited

Organization

Patents Grantslast 30 patents

Chlamydia antigens and corresponding DNA fragments and uses thereof

Transferrin receptor genes of moraxella

Co-expression of recombination proteins

Non-infectious, non-replicating, immunogenic human immunodeficiency...

Multi-component vaccine comprising at least two antigens from haemo...

Chlamydia antigens and corresponding DNA fragments and uses thereof

Macrophage-infecting parasites expressing a granulocyte macrophage...

Protective recombinant Haemophilus influenzae high molecular weight...

Immunogenic compositions for protection against chlamydial infection

Chlamydia antigens and corresponding DNA fragments and uses thereof

Adjuvant compositions containing more than one adjuvant

Nucleic acid molecules encoding POMP91A protein of Chlamydia

Nucleic acid molecules encoding inclusion membrane protein C of Chl...

Nucleic acid respiratory syncytial virus vaccines

Two-step immunization procedure against Chlamydia infection

Chlamydia antigens and corresponding DNA fragments and uses thereof

Multi oligosaccharide glycoconjugate bacterial meningitis vaccines

Chlamydia antigens and corresponding DNA fragments and uses thereof

Chlamydia antigens and corresponding DNA fragments and uses thereof

Chlamydial vaccines and immunogenic compositions containing an oute...

DNA immunization against chlamydia infection

Biodegradable targetable microparticle delivery system

Constitutive expression of non-infectious HIV-like particles

Attenuated strains of mycobacteria

Non-infectious, immunogenic, human immunodeficiency virus-like part...

Anigenically-marked non-infectious retrovirus-like particles

Continuous adherent melanocyte cell line

Nucleic acid molecules encoding inclusion membrane protein C of Chl...

Antigentically-marked non-infectious retrovirus-like particles

Attenuated strains of mycobacteria

Patents Applicationslast 30 patents

TUMOR ANTIGENS BFA4 AND BCY1 FOR PREVENTION AND / OR TREATMENT OF C...

CHLAMYDIA ANTIGENS AND PROTEIN VACCINE

CHLAMYDIA POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS AND USES THE...

Chlamydia OMP antigen

Chlamydia flagellar protein antigen

Nucleic acid and amino acid sequences relating to Streptococcus pne...

Nucleic acid and amino acid sequences relating to streptococcus pne...

Nucleic acid and amino acid sequences relating to Streptococcus pne...

Nucleic acid and amino acid sequences relating to Streptococcus pne...

Nucleic acid and amino acid sequences relating to streptococcus pne...

Nucleic acid and amino acid sequences relating to streptococcus pne...

Nucleic acid and amino acid sequences relating to Streptococcus pne...

Nucleic acid and amino acid sequences relating to Streptococcus pne...

Intranasal delivery of pneumococcal polysaccharide vaccines

Multi-antigen vectors of melanoma

Chlamydia antigens and corresponding DNA fragments and uses thereof

Chlamydia antigens and vaccine uses of the protein

Chlamydia antigens and corresponding DNA fragments and uses thereof

Tumor antigen BFA5 for prevention and / or treatment of cancer

Chlamydia antigens and corresponding DNA fragments and uses thereof

Assaying the teichoic acids of gram+ bacteria

Chlamydia antigens and corresponding DNA fragments and uses thereof

Adjuvant for vaccine composition

Chlamydia antigens and corresponding DNA fragments and uses thereof

Enhancement of the immune response using CD36-binding domain

Vaccine composition comprising iron phosphate as vaccine adjuvant

Tumor antigens BFA4 and BCY1 for prevention and / or treatment of c...

Conjugates obtained by reductive amination of the pneumococcus sero...

Chlamydia antigens and corresponding DNA fragments and uses thereof

Targeted immunogens

Trademarklast 30 trademarks